Felipe Villena

Felipe Villena advises corporates, financial institutions, PE and VC funds on domestic and cross-border M&A and venture capital transactions with a focus on deals in the infrastructure sector. Felipe has many years of experience with assets in the transportation and logistics sector (in particular rolling stock, shipping and aviation) as well as in the renewable energy and clean tech sector.

Venture Capital in CleanTech and Renewables

Download our brochure

CV

Since 2023 Salary Partner, Taylor Wessing

2021 - 2023 Senior Associate, Taylor Wessing

2017 – 2021 Associate, Freshfields Bruckhaus Deringer

Carrière

Since 2023 Salary Partner, Taylor Wessing

2021 - 2023 Senior Associate, Taylor Wessing

2017 – 2021 Associate, Freshfields Bruckhaus Deringer

Formation

2018 Admitted to the bar

2017 Second state examination, OLG Koblenz

2014 First state examination Johannes Gutenberg University Mainz

Langues étrangères

Experience

Protembis GmbH on financing by the European Investment Bank

Advised Protembis GmbH, the Aachen-based medical technology start-up, on financing by the European Investment Bank who granted the company a venture debt facility totalling EUR 20 million.

Press release

Felipe Villena

Dr. Jens Wiesner, LL.M. (Chicago)

Dennis Hoppermann

Taylor Wessing advises Staycity on acquisition of Felix Group's aparthotels

Taylor Wessing has advised Irish company Staycity Group on the acquisition of a 74.9% majority stake in Felix Group from denkmalneu GmbH (DMN).

Press release

Dr. Alexander Peinze

Felipe Villena

Sarah Katharina Sylvester

Diana Groß

Dr. Jan Kern

Dr. Thorsten Troge

Franziska Ley, LL.M. (Stellenbosch)

Protembis GmbH on EUR 20,000,000 venture debt financing

Comprehensive legal advice to the medical technology start-up Protembis on raising a EUR 20,000,000 venture debt financing from the European Investment Bank (EIB) to finalise clinical trials and enable the market entry of the ‘ProtEmbo’ filter system. The financing is part of the InvestEU programme.

Press release

Felipe Villena

Dr. Jens Wiesner, LL.M. (Chicago)

Dennis Hoppermann

Formycon

Under the leadership of the Frankfurt-based Taylor-Wessing partners Lars-Gerrit Lüßmann and Michael Sinhart, Formycon AG and ATHOS KG are merging their development activities in the field of so-called biosimilars, the follow-up products of biological medicines (biologics), in a long-term strategic partnership. The centrepiece of this agreement is Formycon AG’s participation in the rights of two biosimilars. The volume of the legally complex transaction (aggregate counter-performance) adds up to approximately 650 million euros.

Press release

Dr. Sebastian Beyer, LL.M. (Auckland)

Tobias Kraut

Felipe Villena

Clemens Niedner

Prof. Dr. Michael Johannes Pils

Marcus Hartmann